MedTrace Logo

GO SOAR1: Post-Operative Morbidity and Mortality Following Gynaecological Oncology Surgery

NCT04579861 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2021-03-09

No results posted yet for this study

Summary

The Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR) will develop a network of gynaecological oncology surgeons, surgical departments and other interested parties that will have the long-term ability to collaborate on outcome studies. The aims of the Collaborative are to:

1. Set the research agenda through research prioritisation in gynaecological oncology surgical outcomes.
2. Gather high quality data via a centralised database accessible to all sites that perform gynaecological oncology surgery.
3. Build sustainable international research by producing protocols/guidelines.
4. Train the researchers and leaders of tomorrow by providing open access to all GO SOAR training materials.

The Collaborative will lead to several studies.

The first GO SOAR collaborative study (GO SOAR1) will evaluate international variation of post-operative morbidity and mortality following gynaecological oncology surgery between country groups defined by the human development index (HDI).

Conditions

  • Gynecologic Cancer
  • Surgery
  • Surgery--Complications

Interventions

OTHER

Prospective data collection following gynaecological oncology surgery

Prospective data collection and entry on database following gynaecological oncology surgery

Sponsors & Collaborators

  • University of Aberdeen

    collaborator OTHER

  • University of Hertfordshire

    collaborator OTHER

  • NHS Grampian

    collaborator OTHER_GOV

  • Queen Mary University of London

    collaborator OTHER

  • European Network of Young Gynae Oncologists

    collaborator UNKNOWN

  • Society of Gynecologic Oncology

    collaborator OTHER

  • Cancer Diseases Hospital

    collaborator UNKNOWN

  • Faiza Gaba

    lead OTHER_GOV

Principal Investigators

  • Faiza Gaba · NHS Grampian

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-19
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579861 on ClinicalTrials.gov